Evidence map›Paper›PMID 26525633›Full record

ArticleAging2015

Kinase overexpressing cancers responsive to drug withdrawal.

Amit Dipak Amin, Soumya S Rajan, Jonathan H Schatz

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amit Dipak AminDepartment of Medicine, Division of Hematology-Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Soumya S RajanSheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Jonathan H SchatzDepartment of Medicine, Division of Hematology-Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Funding

A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene OverdoseR01CA190696 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCHATZ, JONATHAN H · 2014 to 2018
$1.5M
NCI NIH HHS R01 CA190696
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, NeoplasmAnimalsAntineoplastic AgentsHumansNeoplasmsProtein Kinase InhibitorsAntineoplastic AgentsProtein Kinase InhibitorsALKBRAFcancer therapeuticsoncogene overdose

Identifiers

PMID26525633
PMCPMC4637203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.